The nature of self for T cells-a systems-level perspective.

[1]  Nicholas T Ingolia,et al.  Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes. , 2014, Cell reports.

[2]  S Walz,et al.  Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy , 2014, Leukemia.

[3]  P. Cook,et al.  Most Human Proteins Made in Both Nucleus and Cytoplasm Turn Over within Minutes , 2014, PloS one.

[4]  S. Rosenberg,et al.  Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer , 2014, Science.

[5]  Sébastien Lemieux,et al.  Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides , 2014, Nature Communications.

[6]  Arie Admon,et al.  The nature and extent of contributions by defective ribosome products to the HLA peptidome , 2014, Proceedings of the National Academy of Sciences.

[7]  J. Yewdell,et al.  Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors , 2014, Journal of leukocyte biology.

[8]  A. Goldberg,et al.  Re-examining class-I presentation and the DRiP hypothesis. , 2014, Trends in immunology.

[9]  K. Flanigan,et al.  Cryptic MHC class I-binding peptides are revealed by aminoglycoside-induced stop codon read-through into the 3′ UTR , 2014, Proceedings of the National Academy of Sciences.

[10]  S. Ferrone,et al.  IL-27 in Human Secondary Lymphoid Organs Attracts Myeloid Dendritic Cells and Impairs HLA Class I–Restricted Antigen Presentation , 2014, The Journal of Immunology.

[11]  Albert J R Heck,et al.  Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD) , 2014, Proceedings of the National Academy of Sciences.

[12]  S. Rosenberg.  Finding suitable targets is the major obstacle to cancer gene therapy , 2014, Cancer Gene Therapy.

[13]  Nicholas T. Ingolia.  Ribosome profiling: new views of translation, from single codons to genome scale , 2014, Nature Reviews Genetics.

[14]  P. Coulie,et al.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy , 2014, Nature Reviews Cancer.

[15]  J. Wolchok,et al.  Immune modulation in cancer with antibodies. , 2014, Annual review of medicine.

[16]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[17]  Gennifer E. Merrihew,et al.  Proteogenomic database construction driven from large scale RNA-seq data. , 2014, Journal of proteome research.

[18]  Bjoern Peters,et al.  HLA Class I Alleles Are Associated with Peptide-Binding Repertoires of Different Size, Affinity, and Immunogenicity , 2013, The Journal of Immunology.

[19]  R. Holt,et al.  Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer , 2013, Clinical Cancer Research.

[20]  M. Huss,et al.  HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics , 2013, Nature Methods.

[21]  M. Stratton,et al.  Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  N. Restifo,et al.  Reassessing target antigens for adoptive T cell therapy , 2013, Nature Biotechnology.

[23]  J. Yewdell,et al.  Nuclear translation for immunosurveillance , 2013, Proceedings of the National Academy of Sciences.

[24]  G. Millot,et al.  Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway , 2013, Proceedings of the National Academy of Sciences.

[25]  Jérôme Galon,et al.  The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. , 2013, Immunity.

[26]  Nina Hillen,et al.  Exploring the MHC-peptide matrix of central tolerance in the human thymus , 2013, Nature Communications.

[27]  Jimmy Lin,et al.  Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells , 2013, Nature Medicine.

[28]  J. Drijfhout,et al.  Discovery of T Cell Epitopes Implementing HLA-Peptidomics into a Reverse Immunology Approach , 2013, The Journal of Immunology.

[29]  J. Leunissen,et al.  The Human Leukocyte Antigen–presented Ligandome of B Lymphocytes* , 2013, Molecular & Cellular Proteomics.

[30]  Ronald N Germain,et al.  T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens. , 2013, Immunity.

[31]  James McCluskey,et al.  Human leukocyte antigen-associated drug hypersensitivity. , 2013, Current opinion in immunology.

[32]  Anthony W. Purcell,et al.  Kinetics of Antigen Expression and Epitope Presentation during Virus Infection , 2013, PLoS pathogens.

[33]  Pia Kvistborg,et al.  The cancer antigenome , 2012, The EMBO journal.

[34]  D. Matthews,et al.  De novo derivation of proteomes from transcriptomes for transcript and protein identification , 2012, Nature Methods.

[35]  Anthony W. Purcell,et al.  Constitutive and Inflammatory Immunopeptidome of Pancreatic β-Cells , 2012, Diabetes.

[36]  L. Zhao,et al.  Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. , 2012, Blood.

[37]  T. Schumacher,et al.  TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients , 2012, Oncoimmunology.

[38]  N. Shastri,et al.  Leucine-tRNA Initiates at CUG Start Codons for Protein Synthesis and Presentation by MHC Class I , 2012, Science.

[39]  Sébastien Lemieux,et al.  MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. , 2012, Blood.

[40]  Ilka Hoof,et al.  Proteome Sampling by the HLA Class I Antigen Processing Pathway , 2012, PLoS Comput. Biol..

[41]  Philippe Pierre,et al.  Nuclear translation visualized by ribosome-bound nascent chain puromycylation , 2012, The Journal of cell biology.

[42]  T. Schumacher,et al.  Dissection of T-cell antigen specificity in human melanoma. , 2012, Cancer research.

[43]  Steven A. Rosenberg,et al.  Adoptive immunotherapy for cancer: harnessing the T cell response , 2012, Nature Reviews Immunology.

[44]  C. Harding.  Faculty Opinions recommendation of Mice completely lacking immunoproteasomes show major changes in antigen presentation. , 2012 .

[45]  B. J. Van den Eynde,et al.  Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversity. , 2012, Current opinion in immunology.

[46]  J. Neefjes,et al.  Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.

[47]  Martin Kircher,et al.  Deep proteome and transcriptome mapping of a human cancer cell line , 2011, Molecular systems biology.

[48]  J. Ellenberg,et al.  The quantitative proteome of a human cell line , 2011, Molecular systems biology.

[49]  J. Yewdell,et al.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. , 2011, Trends in immunology.

[50]  Edward L. Huttlin,et al.  Systematic and quantitative assessment of the ubiquitin-modified proteome. , 2011, Molecular cell.

[51]  Sébastien Lemieux,et al.  The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation , 2011, Molecular systems biology.

[52]  Michelle S. Scott,et al.  A Quantitative Spatial Proteomics Analysis of Proteome Turnover in Human Cells* , 2011, Molecular & Cellular Proteomics.

[53]  C. Perreault,et al.  Next-generation leukemia immunotherapy. , 2011, Blood.

[54]  P. Kloetzel,et al.  The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed. , 2011, Blood.

[55]  R. Fåhraeus,et al.  Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation , 2011, Proceedings of the National Academy of Sciences.

[56]  N. Shastri,et al.  Non-conventional sources of peptides presented by MHC class I , 2011, Cellular and Molecular Life Sciences.

[57]  S. Stevanović,et al.  Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands , 2011, Cellular and Molecular Life Sciences.

[58]  V. Bafna,et al.  Proteogenomics to discover the full coding content of genomes: a computational perspective. , 2010, Journal of proteomics.

[59]  M. Leppert,et al.  Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. , 2010, Blood.

[60]  Sébastien Lemieux,et al.  Deletion of Immunoproteasome Subunits Imprints on the Transcriptome and Has a Broad Impact on Peptides Presented by Major Histocompatibility Complex I molecules* , 2010, Molecular & Cellular Proteomics.

[61]  M. Bouvier,et al.  MHC class I antigen presentation: learning from viral evasion strategies , 2009, Nature Reviews Immunology.

[62]  W. Gu,et al.  Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses , 2009, Proceedings of the National Academy of Sciences.

[63]  R. Lippé,et al.  Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection , 2009, Nature Immunology.

[64]  E. Caron,et al.  ER stress affects processing of MHC class I-associated peptides , 2009, BMC Immunology.

[65]  H. Rammensee,et al.  A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays. , 2008, Cancer research.

[66]  E. Caron,et al.  The MHC class I peptide repertoire is molded by the transcriptome , 2008, The Journal of experimental medicine.

[67]  M. Carrington,et al.  Phenotype Frequencies of Autosomal Minor Histocompatibility Antigens Display Significant Differences among Populations , 2007, PLoS genetics.

[68]  Mark M Davis,et al.  T cells as a self-referential, sensory organ. , 2007, Annual review of immunology.

[69]  J. Yewdell,et al.  Tight Linkage between Translation and MHC Class I Peptide Ligand Generation Implies Specialized Antigen Processing for Defective Ribosomal Products1 , 2006, The Journal of Immunology.

[70]  K. Camphausen,et al.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy , 2006, The Journal of experimental medicine.

[71]  Ilan Beer,et al.  The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells* , 2006, Molecular & Cellular Proteomics.

[72]  C. Perreault,et al.  T cells targeted against a single minor histocompatibility antigen can cure solid tumors , 2005, Nature Medicine.

[73]  M. Mann,et al.  The abc's (and xyz's) of peptide sequencing , 2004, Nature Reviews Molecular Cell Biology.

[74]  D. Tscharke,et al.  CD8+ T Cell Cross-Priming via Transfer of Proteasome Substrates , 2004, Science.

[75]  R. Kennedy,et al.  Cutting Edge: Class I Presentation of Host Peptides Following HIV Infection1 , 2003, The Journal of Immunology.

[76]  C. Perreault,et al.  Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease , 2001, Nature Medicine.

[77]  N. Shastri,et al.  A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells , 1995, The Journal of experimental medicine.

[78]  C. Perreault,et al.  Rejection of leukemic cells requires antigen-specific T cells with high functional avidity. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[79]  Wei,et al.  Why must T cells be cross-reactive? , 2012 .

[80]  Wilfried Bardet,et al.  HLA class I molecules reflect an altered host proteome after influenza virus infection. , 2010, Human immunology.

[81]  Ilan Beer,et al.  Title: The Turnover Kinetics of MHC Peptides of Human Cancer Cells 1 , 2005 .